4978 — ReproCell Balance Sheet
0.000.00%
- ¥18bn
- ¥14bn
- ¥3bn
- 24
- 10
- 91
- 36
Annual balance sheet for ReproCell, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Yuho | Yuho | Yuho | Yuho | Tanshin |
Standards: | JAS | JAS | JAS | JAS | — |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 4,601 | 4,642 | 6,379 | 6,567 | 3,942 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 180 | 348 | 446 | 421 | 464 |
Total Inventory | |||||
Total Other Current Assets | |||||
Total Current Assets | 5,245 | 5,379 | 7,182 | 7,399 | 4,896 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 174 | 97.8 | 101 | 200 | 242 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 6,047 | 8,095 | 8,356 | 9,053 | 9,671 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 553 | 827 | 750 | 678 | 641 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 663 | 845 | 781 | 741 | 686 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 5,384 | 7,251 | 7,575 | 8,312 | 8,985 |
Total Liabilities & Shareholders' Equity | 6,047 | 8,095 | 8,356 | 9,053 | 9,671 |
Total Common Shares Outstanding |